Skip to content
  • Sunday, 31 May 2026
  • 12:00 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • US Government Assumes Full Cost of Weight Loss Drugs for Medicare Beneficiaries Through Extended GLP-1 Bridge Program Amidst Insurer Hesitation
Pharmaceutical R&D

US Government Assumes Full Cost of Weight Loss Drugs for Medicare Beneficiaries Through Extended GLP-1 Bridge Program Amidst Insurer Hesitation

Teuku Ryan Apr 22, 2026 0

The Centers for Medicare & Medicaid Services (CMS) has announced a significant extension of its Medicare GLP-1 Bridge program, shifting…

Read More
Pharmaceutical R&D

US Government Invests Heavily in Antibiotic Manufacturing to Combat Antimicrobial Resistance

Teuku Ryan Apr 10, 2026 0

The United States government, through the Biomedical Advanced Research and Development Authority (BARDA), has committed up to $482 million to…

Read More
Pharmaceutical R&D

UK Government Overhauls Medicine Regulation to Accelerate Patient Access and Boost Life Sciences Sector

Teuku Ryan Mar 19, 2026 0

The United Kingdom is set to revolutionize its medicine regulation framework, a move poised to significantly expedite patient access to…

Read More
Novo Nordisk’s triple agonist delivers up to 19.7% average weight loss in Phase 2 trialWHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.Novo Nordisk’s new weight loss treatment inferior to Lilly’s tirzepatideLilly’s triple agonist achieves 16.8% weight loss in phase 3 trial
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Innovative Bone Marrow-on-a-Chip Platform Developed by Penn and CHOP Researchers to Revolutionize Drug Testing and Aerospace MedicineProtecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma InnovationStudy Links Vitamin B12 and Folate Deficiencies to Chronic Fatigue and Reduced Motivation in Healthy AdultsEnvironmental Control of Superconductivity in Twisted Bilayer Graphene Opens New Frontiers for Quantum Electronics
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Innovative Bone Marrow-on-a-Chip Platform Developed by Penn and CHOP Researchers to Revolutionize Drug Testing and Aerospace Medicine
Dwi Wanna May 30, 2026
Laboratory Automation & Robotics
Protecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma Innovation
Lana Keisha May 30, 2026
Neuroscience & Brain Research
Study Links Vitamin B12 and Folate Deficiencies to Chronic Fatigue and Reduced Motivation in Healthy Adults
Rifan Muazin May 30, 2026
Advanced Materials Science
Environmental Control of Superconductivity in Twisted Bilayer Graphene Opens New Frontiers for Quantum Electronics
Nila Kartika Wati May 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ